Eye-disease drug-delivery biopharma
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Paul Tudor Jones / Tudor | 63 | Trimmed -55% | 694,063 | $6,815,699 | 0.0% |
| Steve Cohen / Point72 | 80 | Trimmed -41% | 3,292,193 | $32,329,335 | 0.0% |
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-02-24 | LINDSTROM RICHARD L MD | director | 60,229 | $461,354 | Form 4 |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.